NBIX

TYPE Stocks
GROUP Stocks
BASE Neurocrine B...
SECOND
rate-up rate-down <% (signals.list.current.rate).substr(0,7) %>
<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)
MARKETS TREND
OPEN
<% (signals.list.current.openrate).substr(0,9) %>
HIGH
<% (signals.list.current.high).substr(0,9) %>
LOW
<% (signals.list.current.low).substr(0,9) %>
NBIX Signals
DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM
ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM
<% signal.pair %> (<% signal.rate %>) <% signal.action %>
<% signal.status %>
Long Term
Entry Price
Stop Loss
Take Profit
<% signal.entryPrice %> N/A
PREMIUM ONLY
<% signal.stopLoss %> N/A
PREMIUM ONLY
<% signal.takeProfit %> N/A
PREMIUM ONLY
<% signal.comment %>
Description
<% signal.description %>
LATEST ANALYSIS
<% item.time_ago %> Ago
<% item.title %>
<% item.deltaTime %>

Last Updated: Jun 15, 2026 07:35:42 AM (GMT)

NBIX: The current live price is 158.11, reflecting a decrease of -1.76% from the previous price.

Support and Resistance Levels The pivot point is at 158.11, with current support levels at 158.11 and resistance levels at 158.11.

Indicators The current RSI is 13.02, indicating significant bearish momentum as it is falling. The ATR is 0.01286, indicating low volatility, while ADX stands at 76.63, suggesting a strong trend. The Parabolic SAR is at 159.93, and the price is below this. The EMA-5 is at 158.11, confirming a bearish trend.

Market Sentiment The market is bearish given the price is below the pivot point of 158.11, supported by the bearish indicators.

NBIX Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>
Market Trend
Strong Sell
Sell
Neutral
Buy
Strong Buy
Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>
Strong Sell
Sell
Neutral
Buy
Strong Buy

Trend Indicators

NAME
VALUE
ACTION
Bollinger Bands
UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>
MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>
LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>
Sell
Buy
Parabolic SAR
<% indicators.data[indicators.interval.active].sar.value %>
Sell
Buy
Standard Deviation
<% indicators.data[indicators.interval.active].stddev.value %>
High Volatility
Low Volatility

Oscillators

NAME
VALUE
ACTION
RSI(14)
<% indicators.data[indicators.interval.active].rsi.value %>
Sell
Buy
MACD(12,26)
<% indicators.data[indicators.interval.active].macd.value %>
Buy
Sell
Neutral
ATR
<% indicators.data[indicators.interval.active].atr.value %>
High Volatility
Low Volatility
STOCH(9,6)
<% indicators.data[indicators.interval.active].stochastics.value %>
Buy
Sell
ADX
<% indicators.data[indicators.interval.active].adx.value %>
High Volatility
Low Volatility

Moving Averages

PERIOD
SIMPLE
EXPONENTIAL
MA5
<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell
MA10
<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell
MA20
<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell
MA50
<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell
MA100
<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT
CLASSIC
FIBONACCI
CAMARILLA
WOODIE
S3
<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>
S2
<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>
S1
<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>
PP
<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>
R1
<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>
R2
<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>
R3
<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (NBIX) Neurocrine Biosciences Inc.

Company Background

Neurocrine Biosciences Inc. (NASDAQ: NBIX) is a biopharmaceutical company based in the United States that specializes in the development and commercialization of innovative treatments for neurological and endocrine disorders. Founded in 1992, Neurocrine is dedicated to improving the lives of patients through cutting-edge research and a commitment to advancing the science of medicine. The company's proprietary products and pipeline candidate focus on addressing critical unmet medical needs in a variety of therapeutic areas, including disorders related to the brain and hormonal systems.

Market Position

Neurocrine Biosciences has established itself as a leader in the biopharmaceutical industry, particularly in the field of neurology and endocrinology. The company's flagship product, Ingrezza (valbenazine), was approved by the FDA for the treatment of tardive dyskinesia, positioning Neurocrine as a pioneer in this therapeutic area. With a robust pipeline that includes compounds targeting Parkinson's disease, epilepsy, and other central nervous system disorders, Neurocrine is well-positioned to capitalize on the growing demand for advanced treatment options. The company maintains strategic partnerships and collaborations with various research institutions and organizations, enhancing its capabilities and market reach.

Key Financial and Industry Highlights

Neurocrine Biosciences has demonstrated strong financial performance, with significant revenue growth driven by its product portfolio, particularly from Ingrezza. The company reported impressive earnings results, reflecting its operational efficiency and commitment to R&D investment. Neurocrine's solid financial footing allows for continued investment in innovative therapies and the exploration of new treatment options. As the biopharmaceutical landscape evolves, Neurocrine remains committed to addressing pivotal healthcare challenges, with a focus on delivering breakthrough therapies that significantly enhance patient outcomes. The growing prevalence of neurological disorders presents a substantial opportunity for Neurocrine, reinforcing its market position as a key player in the biopharmaceutical sector.

How to Buy or Trade Neurocrine Biosciences Inc. Stock (NBIX) with AvaTrade

Trading or investing in Neurocrine Biosciences Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol NBIX, which represents Neurocrine Biosciences Inc.. Before placing a trade, review the live Neurocrine Biosciences Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.

The next step is deciding whether you want to buy or sell Neurocrine Biosciences Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Neurocrine Biosciences Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.

Related Stocks

ACB logo
ACB
Aurora Cannabis Inc.
0
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
CRON logo
CRON
Cronos Group Inc.
0
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
CGC logo
CGC
Canopy Growth Corporation
0
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ

HFM

HFM rest

Pu Prime

XM

Best Forex Brokers